Skip to main content
Top
Published in: Medical Oncology 1/2017

01-01-2017 | Review Article

Salivary biomarkers in cancer detection

Authors: Xiaoqian Wang, Karolina Elżbieta Kaczor-Urbanowicz, David T. W. Wong

Published in: Medical Oncology | Issue 1/2017

Login to get access

Abstract

Cancer is the second most common cause of death in the USA. Its symptoms are often not specific and absent, until the tumors have already metastasized. Therefore, there is an urgent demand for developing rapid, highly accurate and noninvasive tools for cancer screening, early detection, diagnostics, staging and prognostics. Saliva as a multi-constituent oral fluid comprises secretions from the major and minor salivary glands, extensively supplied by blood. Molecules such as DNAs, RNAs, proteins, metabolites, and microbiota, present in blood, could be also found in saliva. Recently, salivary diagnostics has drawn significant attention for the detection of specific biomarkers, since the sample collection and processing are simple, cost-effective, and precise and do not cause patient discomfort. Here, we review recent salivary candidate biomarkers for systemic cancers by dividing them according to their origin into: genomic, transcriptomic, proteomic, metabolomic and microbial types.
Literature
2.
go back to reference Huang MY, Tsai HL, Huang JJ, Wang JY. Clinical implications and future perspectives of circulating tumor cells and biomarkers in clinical outcomes of colorectal cancer. Transl Oncol. 2016;9:340–7.CrossRefPubMedPubMedCentral Huang MY, Tsai HL, Huang JJ, Wang JY. Clinical implications and future perspectives of circulating tumor cells and biomarkers in clinical outcomes of colorectal cancer. Transl Oncol. 2016;9:340–7.CrossRefPubMedPubMedCentral
3.
go back to reference Soini HA, Klouckova I, Wiesler D, Oberzaucher E, Grammer K, Dixon SJ, et al. Analysis of volatile organic compounds in human saliva by a static sorptive extraction method and gas chromatography-mass spectrometry. J Chem Ecol. 2010;36:1035–42.CrossRefPubMed Soini HA, Klouckova I, Wiesler D, Oberzaucher E, Grammer K, Dixon SJ, et al. Analysis of volatile organic compounds in human saliva by a static sorptive extraction method and gas chromatography-mass spectrometry. J Chem Ecol. 2010;36:1035–42.CrossRefPubMed
4.
go back to reference Aps JK, Martens LC. Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int. 2005;150:119–31.CrossRefPubMed Aps JK, Martens LC. Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int. 2005;150:119–31.CrossRefPubMed
5.
go back to reference Slavkin HC. Toward molecularly based diagnostics for the oral cavity. J Am Dent Assoc. 1998;129:1138–43.CrossRefPubMed Slavkin HC. Toward molecularly based diagnostics for the oral cavity. J Am Dent Assoc. 1998;129:1138–43.CrossRefPubMed
7.
go back to reference Lawrence HP. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc. 2002;68:170–5.PubMed Lawrence HP. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc. 2002;68:170–5.PubMed
8.
go back to reference Rylander-Rudqvist T, Håkansson N, Tybring G, Wolk A. Quality and quantity of saliva DNA obtained from the self-administrated oragene method—a pilot study on the cohort of Swedish men. Cancer Epidemiol Biomark Prev. 2006;15:1742–5.CrossRef Rylander-Rudqvist T, Håkansson N, Tybring G, Wolk A. Quality and quantity of saliva DNA obtained from the self-administrated oragene method—a pilot study on the cohort of Swedish men. Cancer Epidemiol Biomark Prev. 2006;15:1742–5.CrossRef
9.
go back to reference Abraham JE, Maranian MJ, Spiteri I, Russell R, Ingle S, Luccarini C, et al. Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping. BMC Med Genom. 2012;5:19.CrossRef Abraham JE, Maranian MJ, Spiteri I, Russell R, Ingle S, Luccarini C, et al. Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping. BMC Med Genom. 2012;5:19.CrossRef
10.
11.
go back to reference Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 1983;301:89–92.CrossRefPubMed Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 1983;301:89–92.CrossRefPubMed
12.
go back to reference Wei F, Lin CC, Joon A, Feng Z, Troche G, Lira ME, et al. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med. 2014;190:1117–26.CrossRefPubMed Wei F, Lin CC, Joon A, Feng Z, Troche G, Lira ME, et al. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med. 2014;190:1117–26.CrossRefPubMed
13.
go back to reference Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15:5473–7.CrossRefPubMedPubMedCentral Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15:5473–7.CrossRefPubMedPubMedCentral
14.
go back to reference Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J Dent Res. 2004;83:199–203.CrossRefPubMed Li Y, Zhou X, St John MA, Wong DT. RNA profiling of cell-free saliva using microarray technology. J Dent Res. 2004;83:199–203.CrossRefPubMed
15.
go back to reference Lee YH, Zhou H, Reiss JK, Yan X, Zhang L, Chia D, et al. Direct saliva transcriptome analysis. Clin Chem. 2011;57:1295–302.CrossRefPubMed Lee YH, Zhou H, Reiss JK, Yan X, Zhang L, Chia D, et al. Direct saliva transcriptome analysis. Clin Chem. 2011;57:1295–302.CrossRefPubMed
16.
17.
go back to reference Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB, et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci. 2012;69:3341–50.CrossRefPubMedPubMedCentral Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB, et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci. 2012;69:3341–50.CrossRefPubMedPubMedCentral
18.
go back to reference Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138:949–57.CrossRefPubMed Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010;138:949–57.CrossRefPubMed
19.
go back to reference Gao S, Chen LY, Wang P, Liu LM, Chen Z. MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG. Biomed Res Int. 2014;2014:756347.PubMedPubMedCentral Gao S, Chen LY, Wang P, Liu LM, Chen Z. MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with ZHENG. Biomed Res Int. 2014;2014:756347.PubMedPubMedCentral
20.
go back to reference Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS ONE. 2010;5:e15573.CrossRefPubMedPubMedCentral Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS ONE. 2010;5:e15573.CrossRefPubMedPubMedCentral
21.
go back to reference Bassim CW, Ambatipudi KS, Mays JW, Edwards DA, Swatkoski S, Fassil H, et al. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease. J Clin Immunol. 2012;32:1390–9.CrossRefPubMedPubMedCentral Bassim CW, Ambatipudi KS, Mays JW, Edwards DA, Swatkoski S, Fassil H, et al. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease. J Clin Immunol. 2012;32:1390–9.CrossRefPubMedPubMedCentral
23.
go back to reference Papale M, Pedicillo MC, Di Paolo S, Thatcher BJ, Lo Muzio L, Bufo P, et al. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis. Clin Chem Lab Med. 2008;46:89–99.CrossRefPubMed Papale M, Pedicillo MC, Di Paolo S, Thatcher BJ, Lo Muzio L, Bufo P, et al. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis. Clin Chem Lab Med. 2008;46:89–99.CrossRefPubMed
24.
go back to reference Ciavarella D, Mastrovincenzo M, D’Onofrio V, Chimenti C, Parziale V, Barbato E, et al. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study. Prog Orthod. 2011;12:126–31.CrossRefPubMed Ciavarella D, Mastrovincenzo M, D’Onofrio V, Chimenti C, Parziale V, Barbato E, et al. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study. Prog Orthod. 2011;12:126–31.CrossRefPubMed
25.
go back to reference Streckfus CF, Bigler LR, Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J Oral Pathol Med. 2006;35:292–300.CrossRefPubMed Streckfus CF, Bigler LR, Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J Oral Pathol Med. 2006;35:292–300.CrossRefPubMed
26.
go back to reference Li X, Yang T, Lin J. Spectral analysis of human saliva for detection of lung cancer using surface-enhanced Raman spectroscopy. J Biomed Opt. 2012;17:037003.CrossRefPubMed Li X, Yang T, Lin J. Spectral analysis of human saliva for detection of lung cancer using surface-enhanced Raman spectroscopy. J Biomed Opt. 2012;17:037003.CrossRefPubMed
27.
go back to reference Wu W, Gong H, Liu M, Chen G, Chen R. Noninvasive breast tumors detection based on saliva protein surface enhanced Raman spectroscopy and regularized multinomial regression. In: 2015 8th international conference on biomedical engineering and informatics (BMEI). IEEE; 2015. p. 214–218. Wu W, Gong H, Liu M, Chen G, Chen R. Noninvasive breast tumors detection based on saliva protein surface enhanced Raman spectroscopy and regularized multinomial regression. In: 2015 8th international conference on biomedical engineering and informatics (BMEI). IEEE; 2015. p. 214–218.
29.
go back to reference Arakaki AK, Skolnick J, McDonald JF. Marker metabolites can be therapeutic targets as well. Nature. 2008;456:443.CrossRefPubMed Arakaki AK, Skolnick J, McDonald JF. Marker metabolites can be therapeutic targets as well. Nature. 2008;456:443.CrossRefPubMed
30.
go back to reference Park C, Yun S, Lee SY, Park K, Lee J. Metabolic profiling of Klebsiella oxytoca: evaluation of methods for extraction of intracellular metabolites using UPLC/Q-TOF-MS. Appl Biochem Biotechnol. 2012;167:425–38.CrossRefPubMed Park C, Yun S, Lee SY, Park K, Lee J. Metabolic profiling of Klebsiella oxytoca: evaluation of methods for extraction of intracellular metabolites using UPLC/Q-TOF-MS. Appl Biochem Biotechnol. 2012;167:425–38.CrossRefPubMed
31.
go back to reference Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6:78–95.CrossRefPubMed Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010;6:78–95.CrossRefPubMed
32.
go back to reference Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer. 2011;129:2207–17.CrossRefPubMed Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer. 2011;129:2207–17.CrossRefPubMed
33.
go back to reference Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, et al. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013;34:2865–72.PubMed Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, et al. Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013;34:2865–72.PubMed
34.
go back to reference Keijser BJ, Zaura E, Huse SM, van der Vossen JM, Schuren FH, Montijn RC, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res. 2008;87:1016–20.CrossRefPubMed Keijser BJ, Zaura E, Huse SM, van der Vossen JM, Schuren FH, Montijn RC, et al. Pyrosequencing analysis of the oral microflora of healthy adults. J Dent Res. 2008;87:1016–20.CrossRefPubMed
35.
go back to reference Burne RA, Zeng L, Ahn SJ, Palmer SR, Liu Y, Lefebure T, et al. Progress dissecting the oral microbiome in caries and health. Adv Dent Res. 2012;24:77–80.CrossRefPubMedPubMedCentral Burne RA, Zeng L, Ahn SJ, Palmer SR, Liu Y, Lefebure T, et al. Progress dissecting the oral microbiome in caries and health. Adv Dent Res. 2012;24:77–80.CrossRefPubMedPubMedCentral
36.
37.
go back to reference Cox MJ, Cookson WO, Moffatt MF. Sequencing the human microbiome in health and disease. Hum Mol Genet. 2013;22:R88–94.CrossRefPubMed Cox MJ, Cookson WO, Moffatt MF. Sequencing the human microbiome in health and disease. Hum Mol Genet. 2013;22:R88–94.CrossRefPubMed
39.
go back to reference Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61:582–8.CrossRefPubMed Farrell JJ, Zhang L, Zhou H, Chia D, Elashoff D, Akin D, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012;61:582–8.CrossRefPubMed
40.
go back to reference Torres PJ, Fletcher EM, Gibbons SM, Bouvet M, Doran KS, Kelley ST. Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ. 2015;3:e1373.CrossRefPubMedPubMedCentral Torres PJ, Fletcher EM, Gibbons SM, Bouvet M, Doran KS, Kelley ST. Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ. 2015;3:e1373.CrossRefPubMedPubMedCentral
41.
go back to reference Zilberman Y, Sonkusale SR. Microfluidic optoelectronic sensor for salivary diagnostics of stomach cancer. Biosens Bioelectron. 2015;67:465–71.CrossRefPubMed Zilberman Y, Sonkusale SR. Microfluidic optoelectronic sensor for salivary diagnostics of stomach cancer. Biosens Bioelectron. 2015;67:465–71.CrossRefPubMed
42.
go back to reference Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal. 2009;14:e521–4.CrossRefPubMed Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal. 2009;14:e521–4.CrossRefPubMed
43.
go back to reference Lau CS, Wong DT. Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS ONE. 2012;7:e33037.CrossRefPubMedPubMedCentral Lau CS, Wong DT. Breast cancer exosome-like microvesicles and salivary gland cells interplay alters salivary gland cell-derived exosome-like microvesicles in vitro. PLoS ONE. 2012;7:e33037.CrossRefPubMedPubMedCentral
44.
go back to reference Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M, et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res. 2010;51:2105–20.CrossRefPubMedPubMedCentral Subra C, Grand D, Laulagnier K, Stella A, Lambeau G, Paillasse M, et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res. 2010;51:2105–20.CrossRefPubMedPubMedCentral
45.
go back to reference Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–9.CrossRefPubMed Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–9.CrossRefPubMed
47.
go back to reference Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–79.PubMed Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569–79.PubMed
48.
go back to reference Yamada T, Inoshima Y, Matsuda T, Ishiguro N. Comparison of methods for isolating exosomes from bovine milk. J Vet Med Sci. 2012;74:1523–5.CrossRefPubMed Yamada T, Inoshima Y, Matsuda T, Ishiguro N. Comparison of methods for isolating exosomes from bovine milk. J Vet Med Sci. 2012;74:1523–5.CrossRefPubMed
49.
go back to reference Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res. 2009;8:1304–14.CrossRefPubMedPubMedCentral Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). J Proteome Res. 2009;8:1304–14.CrossRefPubMedPubMedCentral
50.
go back to reference Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R. Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull. 2008;31:1059–62.CrossRefPubMed Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R. Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Biol Pharm Bull. 2008;31:1059–62.CrossRefPubMed
51.
go back to reference Mahmoodzadeh Hosseini H, Imani Fooladi AA, Soleimanirad J, Nourani MR, Davaran S, Mahdavi M. Staphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells. Tumour Biol. 2014;35:3699–707.CrossRefPubMed Mahmoodzadeh Hosseini H, Imani Fooladi AA, Soleimanirad J, Nourani MR, Davaran S, Mahdavi M. Staphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells. Tumour Biol. 2014;35:3699–707.CrossRefPubMed
52.
go back to reference Ritchie AJ, Crawford DM, Ferguson DJ, Burthem J, Roberts DJ. Normal prion protein is expressed on exosomes isolated from human plasma. Br J Haematol. 2013;163:678–80.CrossRefPubMed Ritchie AJ, Crawford DM, Ferguson DJ, Burthem J, Roberts DJ. Normal prion protein is expressed on exosomes isolated from human plasma. Br J Haematol. 2013;163:678–80.CrossRefPubMed
53.
go back to reference Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y, et al. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Pharmazie. 2013;68:969–73.PubMed Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y, et al. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Pharmazie. 2013;68:969–73.PubMed
54.
go back to reference Beninson LA, Fleshner M. Exosomes: an emerging factor in stress-induced immunomodulation. Semin Immunol. 2014;26:394–401.CrossRefPubMed Beninson LA, Fleshner M. Exosomes: an emerging factor in stress-induced immunomodulation. Semin Immunol. 2014;26:394–401.CrossRefPubMed
55.
go back to reference O’Loughlin AJ, Woffindale CA, Wood MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther. 2012;12:262–74.CrossRefPubMed O’Loughlin AJ, Woffindale CA, Wood MJ. Exosomes and the emerging field of exosome-based gene therapy. Curr Gene Ther. 2012;12:262–74.CrossRefPubMed
56.
go back to reference Lau C, Kim Y, Chia D, Spielmann N, Eibl G, Elashoff D, et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem. 2013;288:26888–97.CrossRefPubMedPubMedCentral Lau C, Kim Y, Chia D, Spielmann N, Eibl G, Elashoff D, et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem. 2013;288:26888–97.CrossRefPubMedPubMedCentral
57.
go back to reference Pu D, Liang H, Wei F, Akin D, Feng Z, Yan Q, et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: a pilot study. Thorac Cancer. 2016;7:428–36.CrossRefPubMedPubMedCentral Pu D, Liang H, Wei F, Akin D, Feng Z, Yan Q, et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: a pilot study. Thorac Cancer. 2016;7:428–36.CrossRefPubMedPubMedCentral
58.
go back to reference Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteom. 2012;11(M111):012112. Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteom. 2012;11(M111):012112.
59.
go back to reference Jenkinson C, Earl J, Ghaneh P, Halloran C, Carrato A, Greenhalf W, et al. Biomarkers for early diagnosis of pancreatic cancer. Expert Rev Gastroenterol Hepatol. 2015;9:305–15.CrossRefPubMed Jenkinson C, Earl J, Ghaneh P, Halloran C, Carrato A, Greenhalf W, et al. Biomarkers for early diagnosis of pancreatic cancer. Expert Rev Gastroenterol Hepatol. 2015;9:305–15.CrossRefPubMed
61.
go back to reference Humeau M, Vignolle-Vidoni A, Sicard F, Martins F, Bournet B, Buscail L, et al. Salivary microRNA in pancreatic cancer patients. PLoS ONE. 2015;10:e0130996.CrossRefPubMedPubMedCentral Humeau M, Vignolle-Vidoni A, Sicard F, Martins F, Bournet B, Buscail L, et al. Salivary microRNA in pancreatic cancer patients. PLoS ONE. 2015;10:e0130996.CrossRefPubMedPubMedCentral
62.
go back to reference Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila). 2015;8:165–73.CrossRef Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, et al. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila). 2015;8:165–73.CrossRef
63.
go back to reference Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50:3–14.CrossRefPubMed Skaane P. Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review. Acta Radiol. 2009;50:3–14.CrossRefPubMed
64.
go back to reference Laidi F, Bouziane A, Lakhdar A, Khabouze S, Amrani M, Rhrab B, et al. Significant correlation between salivary and serum Ca 15-3 in healthy women and breast cancer patients. Asian Pac J Cancer Prev. 2014;15:4659–62.CrossRefPubMed Laidi F, Bouziane A, Lakhdar A, Khabouze S, Amrani M, Rhrab B, et al. Significant correlation between salivary and serum Ca 15-3 in healthy women and breast cancer patients. Asian Pac J Cancer Prev. 2014;15:4659–62.CrossRefPubMed
65.
go back to reference Füzéry AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteom. 2013;10:13.CrossRef Füzéry AK, Levin J, Chan MM, Chan DW. Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges. Clin Proteom. 2013;10:13.CrossRef
66.
go back to reference Wood N, Streckfus CF. The expression of lung resistance protein in saliva: a novel prognostic indicator protein for carcinoma of the breast. Cancer Investig. 2015;33:510–5.CrossRef Wood N, Streckfus CF. The expression of lung resistance protein in saliva: a novel prognostic indicator protein for carcinoma of the breast. Cancer Investig. 2015;33:510–5.CrossRef
67.
go back to reference Jinno H, Murata T, Sunamura M, Sugimoto M. Investigation of potential salivary biomarkers for the diagnosis of breast cancer. In: ASCO annual meeting proceedings; 2015. p. 145. Jinno H, Murata T, Sunamura M, Sugimoto M. Investigation of potential salivary biomarkers for the diagnosis of breast cancer. In: ASCO annual meeting proceedings; 2015. p. 145.
68.
go back to reference Zhong L, Cheng F, Lu X, Duan Y, Wang X. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Talanta. 2016;158:351–60.CrossRefPubMed Zhong L, Cheng F, Lu X, Duan Y, Wang X. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations. Talanta. 2016;158:351–60.CrossRefPubMed
69.
go back to reference Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.CrossRefPubMed
70.
go back to reference Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol. 2009;15:865–70.CrossRefPubMedPubMedCentral Wu ZZ, Wang JG, Zhang XL. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol. 2009;15:865–70.CrossRefPubMedPubMedCentral
71.
go back to reference Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep. 2016;6:22165.CrossRefPubMedPubMedCentral Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep. 2016;6:22165.CrossRefPubMedPubMedCentral
Metadata
Title
Salivary biomarkers in cancer detection
Authors
Xiaoqian Wang
Karolina Elżbieta Kaczor-Urbanowicz
David T. W. Wong
Publication date
01-01-2017
Publisher
Springer US
Published in
Medical Oncology / Issue 1/2017
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-016-0863-4

Other articles of this Issue 1/2017

Medical Oncology 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.